MAM

MPM Asset Management Portfolio holdings

AUM $43.3M
This Quarter Return
+6.66%
1 Year Return
-54.44%
3 Year Return
+14.05%
5 Year Return
-29.8%
10 Year Return
-11.6%
AUM
$469M
AUM Growth
+$469M
Cap. Flow
-$4.7M
Cap. Flow %
-1%
Top 10 Hldgs %
97.65%
Holding
15
New
–
Increased
–
Reduced
1
Closed
–

Top Buys

No buys this quarter

Top Sells

1
EPZM
Epizyme, Inc
EPZM
$4.7M

Sector Composition

1 Healthcare 27.73%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
RDUS
1
DELISTED
Radius Health, Inc.
RDUS
$240M 51.18%
5,831,253
– –
PTLA
2
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$46.3M 9.88%
1,220,672
– –
EPZM
3
DELISTED
Epizyme, Inc
EPZM
$40.6M 8.67%
2,163,819
-250,000
-10% -$4.7M
PETX
4
DELISTED
Aratana Therapeutics, Inc.
PETX
$33.9M 7.23%
2,118,845
– –
NVRO
5
DELISTED
NEVRO CORP.
NVRO
$32.9M 7.02%
686,704
– –
TRIV
6
DELISTED
TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK
TRIV
$18.6M 3.97%
1,776,692
– –
EIGR
7
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$15.2M 3.23%
800,542
– –
TARA icon
8
Protara Therapeutics
TARA
$120M
$11.4M 2.44%
983,381
– –
ALT icon
9
Altimmune
ALT
$338M
$10.3M 2.21%
6,347,614
– –
HSTO
10
DELISTED
Histogen Inc. Common Stock
HSTO
$8.49M 1.81%
1,192,080
– –
VSTM icon
11
Verastem
VSTM
$569M
$8.31M 1.77%
816,683
– –
SVRA icon
12
Savara
SVRA
$567M
$1.25M 0.27%
2,551,851
– –
ETRM
13
DELISTED
EnteroMedics Inc.
ETRM
$1.02M 0.22%
1,113,168
– –
SGMO icon
14
Sangamo Therapeutics
SGMO
$157M
$353K 0.08%
22,487
– –
MGNX icon
15
MacroGenics
MGNX
$112M
$99K 0.02%
3,168
– –